Ligand Pharmaceuticals | LGND - 员工总数

股票价格

202.33

每天变化

-2.48 -1.21%

每月一次

7.05%

每年

81.19%

Q1 预测

198.67

金融业

USD

USD 1.56B

现金及等价物

USD 174.93M

USD 11.9M

USD 832.27M

USD 37.45M

USD 451M

USD 158.89M

USD 150.32M

68

EPS每股收益

USD 2.02

股本和储备

USD 1.02B

USD 155.28M

债务利息支出

USD 910K

USD 3.87M

USD 445.49M

USD 3.63B

USD 117.27M

USD 8.29M

USD 158.89M

普通股股本

USD 19.66M

60.65

USD 141.14M

USD 59.66M

销售和管理费用

USD 28.45M

USD 9.13M

贸易债权人

USD 3.24M

应收帐款人

USD 58.1M

	员工	更改		日
Agenus	389		144	2023-12
Amgen	28K		1.3K	2024-12
Anika Therapeutics	357		12	2023-12
Arrowhead Research	711		102	2025-12
Baxter International	38K		22K	2024-12
Bristol-Myers Squibb	34.1K		0	2024-12
Eli Lilly	47K		4K	2024-12
Enanta Pharmaceuticals	145		15	2023-09
Enviri Corporation	13K		1000	2023-12
Gilead Sciences	17.6K		400	2024-12
GlaxoSmithKline	69.4K		20.7K	2022-12
Glaxosmithkline	GBP 69.4K		20.7K	2022-12
Heron Therapeutics	126		77	2023-12
Insmed	1.27K		359	2024-12
Intrexon	202		7	2023-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Karyopharm Therapeutics	325		60	2023-12
Ligand Pharmaceuticals	68		10	2024-12
MacroGenics	339		18	2023-12
Merck	75K		3K	2024-12
Pacira	790		79	2024-12
Pfizer	81K		7K	2024-12
Rigel Pharmaceuticals	147		8	2023-12
Sangamo BioSciences	405		73	2023-12
Veracyte	824		9	2024-12